{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:15:07Z","timestamp":1765959307686},"reference-count":30,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.vaccine.2005.07.013","type":"journal-article","created":{"date-parts":[[2005,7,23]],"date-time":"2005-07-23T12:07:56Z","timestamp":1122120476000},"page":"3727-3734","source":"Crossref","is-referenced-by-count":41,"title":["Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model"],"prefix":"10.1016","volume":"24","author":[{"given":"Eileen M.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2005.07.013_bib1","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"8212","key":"10.1016\/j.vaccine.2005.07.013_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(81)90719-4","article-title":"Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development","volume":"1","author":"Black","year":"1981","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.vaccine.2005.07.013_bib3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJM199111143252006","article-title":"Diarrheal disease during Operation Desert Shield","volume":"325","author":"Hyams","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.013_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JCM.31.4.851-856.1993","article-title":"Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East","volume":"31","author":"Wolf","year":"1993","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.013_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/milmed\/156.1.27","article-title":"Travelers\u2019 diarrhea among United States military personnel during joint American\u2013Egyptian armed forces exercises in Cairo","volume":"156","author":"Haberberger","year":"1991","journal-title":"Egypt Mil Med"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.013_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bpg.2003.11.004","article-title":"Microbial-gut interactions in health and disease. Progress in enteric vaccine development","volume":"18","author":"Svennerholm","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.vaccine.2005.07.013_bib7","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1128\/JCM.41.11.5053-5058.2003","article-title":"Temporal shifts in the dominance of serotypes of Shigella dysenteriae from 1999 to 2002 in Dhaka, Bangladesh","volume":"41","author":"Talukder","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.013_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/infdis\/122.3.181","article-title":"Epidemic Shiga bacillus dysentery in Central America. II. Epidemiologic studies in 1969","volume":"122","author":"Gangarosa","year":"1970","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.013_bib9","first-page":"457","article-title":"Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains","volume":"45","author":"Mel","year":"1971","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.013_bib10","first-page":"647","article-title":"Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial","volume":"32","author":"Mel","year":"1965","journal-title":"Bull World Health Organ"},{"issue":"7","key":"10.1016\/j.vaccine.2005.07.013_bib11","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.013_bib12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for cross-protection among Shigella flexneri serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect Immun"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2005.07.013_bib13","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/clinids\/8.Supplement_2.S131","article-title":"Pathogens that cause travelers\u2019 diarrhea in Latin America and Africa","volume":"8","author":"Black","year":"1986","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.013_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/IAI.23.3.729-736.1979","article-title":"Immunity to enterotoxigenic Escherichia coli","volume":"23","author":"Levine","year":"1979","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.013_bib15","series-title":"Fimbrial vaccines","author":"Levine","year":"1994"},{"issue":"12","key":"10.1016\/j.vaccine.2005.07.013_bib16","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1086\/345817","article-title":"Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau","volume":"186","author":"Steinsland","year":"2002","journal-title":"J Infect Dis"},{"issue":"8778","key":"10.1016\/j.vaccine.2005.07.013_bib17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers\u2019 diarrhoea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.013_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/JB.75.5.604-610.1958","article-title":"Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs","volume":"75","author":"Formal","year":"1958","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.013_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/JB.92.1.17-22.1966","article-title":"Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine","volume":"92","author":"Formal","year":"1966","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.013_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/infdis\/127.3.261","article-title":"Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery","volume":"127","author":"Levine","year":"1973","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.013_bib21","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1128\/IAI.64.8.3055-3061.1996","article-title":"Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine","volume":"64","author":"Noriega","year":"1996","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2005.07.013_bib22","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/IAI.62.11.5168-5172.1994","article-title":"Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine","volume":"62","author":"Noriega","year":"1994","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.013_bib23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/IAI.71.3.1352-1360.2003","article-title":"Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain","volume":"71","author":"Altboum","year":"2003","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2005.07.013_bib24","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1128\/IAI.67.12.6424-6433.1999","article-title":"Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA","volume":"67","author":"Galen","year":"1999","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.013_bib25","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/IAI.68.9.4884-4892.2000","article-title":"Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli","volume":"68","author":"Koprowski","year":"2000","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.013_bib26","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1128\/IAI.69.5.3150-3158.2001","article-title":"Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection","volume":"69","author":"Altboum","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.013_bib27","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/IAI.68.9.4884-4892.2000","article-title":"Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli","volume":"68","author":"Koprowski","year":"2000","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.013_bib28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/424680","article-title":"Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a Bearing Guanine Auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208","volume":"190","author":"Kotloff","year":"2004","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.013_bib29","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1084\/jem.180.6.2147","article-title":"A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit","volume":"180","author":"Pizza","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.013_bib30","doi-asserted-by":"crossref","unstructured":"Barry EM, Altboum Z, Losonsky G, Levine M.M. Immune responses elicited against multiple fimbriae and mutant LT from enterotoxigenic E. coli expressed in attenuated Shigella vaccine strains. Vaccine 21, 333\u2013340.","DOI":"10.1016\/S0264-410X(02)00611-4"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500664X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500664X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T22:59:48Z","timestamp":1626217188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0500664X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0264410X0500664X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}